Maryland Senate Bill 1021

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 2 2024 - 25% progression, died in committee
Action: 2024-02-06 - Hearing 3/13 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimburse the pharmacy; and altering the definition of "purchaser" for purposes of certain provisions of law regulating pharmacy benefits managers to include certain insurers, nonprofit health service plans, and health maintenance organizations.

Pharmacy Benefits Administration - Maryland Medical Assistance Program and Pharmacy Benefits Managers

Sen. Alonzo Washington [D]

Date	Chamber	Action
2024-02-06	Senate	Hearing 3/13 at 1:00 p.m.
2024-02-02	Senate	First Reading Finance

HB880 (Crossfiled) 2024-02-09 - Hearing 2/29 at 1:00 p.m.
SB895 (Carry Over) 2023-03-20 - Hearing canceled

Chapter	Article	Section	Citation Type	Statute Text
Health - General	15	118	(n/a)	See Bill Text
Insurance	15	1601	(n/a)	See Bill Text
Insurance	15	1632	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB1021?ys=2024RS
Text	https://mgaleg.maryland.gov/2024RS/bills/sb/sb1021f.pdf